Reneo Pharmaceuticals Stock Buy Hold or Sell Recommendation
| RPHM Stock | USD 1.68 0.01 0.59% |
Given the investment horizon of 90 days and your above-average risk tolerance, our recommendation regarding Reneo Pharmaceuticals is 'Hold'. Macroaxis provides Reneo Pharmaceuticals buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding RPHM positions. The advice algorithm takes into account all of Reneo Pharmaceuticals' available fundamental, technical, and predictive indicators you will find on this site. Key drivers impacting Reneo Pharmaceuticals' buy or sell advice are summarized below:
Real Value 7.69 | Target Price 25.71 | Hype Value 1.68 | Market Value 1.68 |
A buy or sell recommendation provided by Macroaxis is an automated directive regarding whether to purchase or sell Reneo Pharmaceuticals given historical horizon and risk tolerance towards Reneo Pharmaceuticals. When Macroaxis issues a 'buy' or 'sell' recommendation for Reneo Pharmaceuticals, the advice is generated through an automated system that utilizes algorithms and statistical models.
Reneo |
Execute Reneo Pharmaceuticals Buy or Sell Advice
The Reneo recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Reneo Pharmaceuticals. Macroaxis does not own or have any residual interests in Reneo Pharmaceuticals or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Reneo Pharmaceuticals' advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Hold
Market Performance | Weak | Details | |
Volatility | Somewhat reliable | Details | |
Hype Condition | Stale | Details | |
Current Valuation | Undervalued | Details | |
Odds Of Distress | Low | Details | |
Economic Sensitivity | Barely shadows the market | Details | |
Investor Sentiment | Alarmed | Details | |
Analyst Consensus | Hold | Details | |
Financial Strenth (F Score) | Frail | Details | |
Financial Leverage | Inapplicable | Details | |
Reporting Quality (M-Score) | Unlikely Manipulator | Details |
Reneo Pharmaceuticals Trading Alerts and Improvement Suggestions
| Reneo Pharmaceuticals may become a speculative penny stock | |
| Net Loss for the year was (77.39 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Reneo Pharmaceuticals currently holds about 126.85 M in cash with (63.68 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 5.18, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Reneo Pharmaceuticals has a frail financial position based on the latest SEC disclosures | |
| Over 82.0% of the company shares are owned by institutional investors | |
| Latest headline from news.google.com: Reneo Pharmaceuticals, Inc.s largest shareholders are private equity firms who were rewarded as ... - Yahoo Movies UK |
Reneo Pharmaceuticals Returns Distribution Density
The distribution of Reneo Pharmaceuticals' historical returns is an attempt to chart the uncertainty of Reneo Pharmaceuticals' future price movements. The chart of the probability distribution of Reneo Pharmaceuticals daily returns describes the distribution of returns around its average expected value. We use Reneo Pharmaceuticals price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Reneo Pharmaceuticals returns is essential to provide solid investment advice for Reneo Pharmaceuticals.
| Mean Return | 0.06 | Value At Risk | -2.94 | Potential Upside | 3.75 | Standard Deviation | 2.06 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Reneo Pharmaceuticals historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Reneo Stock Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Reneo Pharmaceuticals is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Reneo Pharmaceuticals backward and forwards among themselves. Reneo Pharmaceuticals' institutional investor refers to the entity that pools money to purchase Reneo Pharmaceuticals' securities or originates loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Renaissance Technologies Corp | 2023-12-31 | 400.4 K | Vestal Point Capital Lp | 2023-12-31 | 400 K | Geode Capital Management, Llc | 2023-12-31 | 339.5 K | State Street Corporation | 2023-12-31 | 247.4 K | Two Sigma Investments Llc | 2023-12-31 | 182.5 K | Millennium Management Llc | 2023-12-31 | 158.9 K | Goldman Sachs Group Inc | 2023-12-31 | 129.6 K | Morgan Stanley - Brokerage Accounts | 2023-12-31 | 124.9 K | Boothbay Fund Management, Llc | 2023-12-31 | 119.6 K | Nea Management Company, Llc | 2023-12-31 | 4.8 M | The Carlyle Group Inc | 2023-12-31 | 2.7 M |
Reneo Pharmaceuticals Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Reneo Pharmaceuticals or Biotechnology sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Reneo Pharmaceuticals' price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Reneo stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over NYSE Composite | 0.05 | |
β | Beta against NYSE Composite | 0.02 | |
σ | Overall volatility | 1.96 | |
Ir | Information ratio | -0.02 |
Reneo Pharmaceuticals Volatility Alert
Reneo Pharmaceuticals has relatively low volatility with skewness of 0.94 and kurtosis of 1.94. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Reneo Pharmaceuticals' stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Reneo Pharmaceuticals' stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.Reneo Pharmaceuticals Fundamentals Vs Peers
Comparing Reneo Pharmaceuticals' fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Reneo Pharmaceuticals' direct or indirect competition across all of the common fundamentals between Reneo Pharmaceuticals and the related equities. This way, we can detect undervalued stocks with similar characteristics as Reneo Pharmaceuticals or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Reneo Pharmaceuticals' fundamental indicators could also be used in its relative valuation, which is a method of valuing Reneo Pharmaceuticals by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Reneo Pharmaceuticals to competition |
| Fundamentals | Reneo Pharmaceuticals | Peer Average |
| Return On Equity | -0.82 | -0.31 |
| Return On Asset | -0.48 | -0.14 |
| Current Valuation | (45.51 M) | 16.62 B |
| Shares Outstanding | 33.42 M | 571.82 M |
| Shares Owned By Insiders | 3.00 % | 10.09 % |
| Shares Owned By Institutions | 82.14 % | 39.21 % |
| Number Of Shares Shorted | 2.92 M | 4.71 M |
| Price To Book | 0.65 X | 9.51 X |
| EBITDA | (82.23 M) | 3.9 B |
| Net Income | (77.39 M) | 570.98 M |
| Cash And Equivalents | 126.85 M | 2.7 B |
| Cash Per Share | 5.18 X | 5.01 X |
| Total Debt | 1.46 M | 5.32 B |
| Debt To Equity | 0.01 % | 48.70 % |
| Current Ratio | 15.84 X | 2.16 X |
| Book Value Per Share | 2.65 X | 1.93 K |
| Cash Flow From Operations | (63.68 M) | 971.22 M |
| Short Ratio | 17.80 X | 4.00 X |
| Earnings Per Share | (2.52) X | 3.12 X |
| Target Price | 1.68 | |
| Number Of Employees | 8 | 18.84 K |
| Beta | 0.24 | -0.15 |
| Market Capitalization | 56.48 M | 19.03 B |
| Total Asset | 107.44 M | 29.47 B |
| Retained Earnings | (218.47 M) | 9.33 B |
| Working Capital | 88.44 M | 1.48 B |
| Net Asset | 107.44 M |
Note: Insider Trading [view details]
Reneo Pharmaceuticals Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Reneo . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Accumulation Distribution | 3634.6 | |||
| Daily Balance Of Power | (0.12) | |||
| Rate Of Daily Change | 0.99 | |||
| Day Median Price | 1.68 | |||
| Day Typical Price | 1.68 | |||
| Price Action Indicator | (0.01) | |||
| Period Momentum Indicator | (0.01) |
About Reneo Pharmaceuticals Buy or Sell Advice
When is the right time to buy or sell Reneo Pharmaceuticals? Buying financial instruments such as Reneo Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.| 2021 | 2023 | 2024 (projected) | Short and Long Term Debt Total | 1.5M | 1.3M | 1.3M | Total Assets | 154.0M | 107.4M | 99.1M |
Use Investing Ideas to Build Portfolios
In addition to having Reneo Pharmaceuticals in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Utilities ETFs Thematic Idea Now
Utilities ETFs
ETF themes focus on helping investors to gain exposure to a broad range of assets, diversify, and lower overall costs. The Utilities ETFs theme has 13 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Utilities ETFs Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Reneo Pharmaceuticals Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. To learn how to invest in Reneo Stock, please use our How to Invest in Reneo Pharmaceuticals guide.Note that the Reneo Pharmaceuticals information on this page should be used as a complementary analysis to other Reneo Pharmaceuticals' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Commodity Channel module to use Commodity Channel Index to analyze current equity momentum.
Complementary Tools for Reneo Stock analysis
When running Reneo Pharmaceuticals' price analysis, check to measure Reneo Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Reneo Pharmaceuticals is operating at the current time. Most of Reneo Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Reneo Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Reneo Pharmaceuticals' price. Additionally, you may evaluate how the addition of Reneo Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
| Stocks Directory Find actively traded stocks across global markets | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA |
Is Reneo Pharmaceuticals' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Reneo Pharmaceuticals. If investors know Reneo will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Reneo Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.52) | Return On Assets (0.48) | Return On Equity (0.82) |
The market value of Reneo Pharmaceuticals is measured differently than its book value, which is the value of Reneo that is recorded on the company's balance sheet. Investors also form their own opinion of Reneo Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Reneo Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Reneo Pharmaceuticals' market value can be influenced by many factors that don't directly affect Reneo Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Reneo Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Reneo Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Reneo Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.